GoodRx vs Polly
Neither GoodRx nor Polly has an FDA warning letter on record. No price lines up like for like: GoodRx and Polly publish prices for different products.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
GoodRx / Polly
GoodRx
7.8/10
Polly
8.4/10
Neither GoodRx nor Polly pays us. Links to them earn nothing. Scores: GoodRx 7.8, Polly 8.4. How we are paid
What the record shows
- 01
Neither GoodRx nor Polly has an FDA warning letter on record.
- 02
Polly names two pharmacies, all 503A. GoodRx sells brand-name medication only.
- 03
No price lines up like for like: GoodRx and Polly publish prices for different products.
- 04
Only GoodRx lists a price for brand-name tirzepatide pen and Foundayo (orforglipron) pill. Only Polly lists a price for compounded semaglutide injection and compounded tirzepatide injection.
- 05
Polly covers two states GoodRx does not.
- 06
GoodRx states you can cancel at any time; Polly does not state its cancellation terms.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
GoodRx
Polly
$179/mo
$2,148 a year
$279/mo
$3,348 a year
$299/mo
$3,588 a year
$149/mo
$1,788 a year
Read off each seller’s own pages. GoodRx: October 30, 2026. Polly: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for GoodRx
7.8/10- Sells brand-name tirzepatide pen and Foundayo (orforglipron) pill, which Polly does not price
- States you can cancel at any time
The case for Polly
8.4/10- Sells compounded semaglutide injection and compounded tirzepatide injection, which GoodRx does not price
Scores
GoodRx 7.8 · Polly 8.4 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
GoodRx vs Polly: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Collective9.1
From $59/mo
Visit site - Eden8.7
From $99/mo
Visit site - Luvo Health7.9
From $179/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks